Cells and prions: A license to replicate

FEBS Letters

Volumn 583, Issue 16, 2009, Pages 2674-2684

  Nuvolone, Mario ^a,b   Aguzzi, Adriano ^a   Heikenwalder, Mathias ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

Follicular dendritic cell; Mesenchymal progenitor cell; Neuroinvasion; Prion replication competence; Stromal inflammatory cell

Indexed keywords

BAMINERCEPT ALPHA; CORTICOSTEROID; CPG OLIGODEOXYNUCLEOTIDE; IMMUNOGLOBULIN; LYMPHOTOXIN BETA RECEPTOR; PRION PROTEIN; PRION PROTEIN ANTIBODY; RECOMBINANT PRION PROTEIN; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

CELL TYPE; CLINICAL TRIAL; DEGENERATIVE DISEASE; DRUG MECHANISM; DRUG SCREENING; FOLLICULAR DENDRITIC CELL; HUMAN; IMMUNE SYSTEM; IMMUNIZATION; IMMUNOTHERAPY; INFLAMMATORY CELL; LYMPHOID ORGAN; MESENCHYMAL STEM CELL; NERVE DEGENERATION; NONHUMAN; PERIPHERAL NERVE; PRION; PRION DISEASE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEIN FOLDING; PROTEIN FUNCTION; REPEATED DRUG DOSE; RHEUMATOID ARTHRITIS; SHORT SURVEY; SIGNAL TRANSDUCTION; STROMA CELL; VIRUS DETECTION; VIRUS REPLICATION; VIRUS STRAIN; VIRUS TRANSMISSION;

ANIMALS; CELLS; HUMANS; IMMUNE SYSTEM; IMMUNOTHERAPY; MICE; PRION DISEASES; PRIONS;

EID: 68649118065     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2009.06.014     Document Type: Short Survey

References (157)

1. Collinge J. Molecular neurology of prion disease. J. Neurol. Neurosurg. Psychiatr. 76 (2005) 906-919
2. Aguzzi A., and Polymenidou M. Mammalian prion biology: one century of evolving concepts. Cell 116 (2004) 313-327
3. Mabbott N.A., and MacPherson G.G. Prions and their lethal journey to the brain. Nat. Rev. Microbiol. 4 (2006) 201-211
4. Gajdusek D.C., and Zigas V. Degenerative disease of the central nervous system in New Guinea - the endemic occurrence of 'kuru'in the native population. New Engl. J. Med. 257 (1957) 974-978
5. Collinge J., and Rossor M. A new variant of prion disease. Lancet 347 (1996) 916-917
6. Will R.G., et al. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 347 (1996) 921-925
7. Llewelyn C.A., Hewitt P.E., Knight R.S., Amar K., Cousens S., Mackenzie J., and Will R.G. Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet 363 (2004) 417-421
8. Aguzzi A., and Glatzel M. Prion infections, blood and transfusions. Nat. Clin. Pract. Neurol. 2 (2006) 321-329
9. Raeber A.J., et al. Ectopic expression of prion protein (PrP) in T lymphocytes or hepatocytes of PrP knockout mice is insufficient to sustain prion replication. Proc. Natl. Acad. Sci. USA 96 (1999) 3987-3992
10. Raeber A.J., Klein M.A., Frigg R., Flechsig E., Aguzzi A., and Weissmann C. PrP-dependent association of prions with splenic but not circulating lymphocytes of scrapie-infected mice. EMBO J. 18 (1999) 2702-2706
11. Aguzzi A. Prion biology: the quest for the test. Nat. Meth. 4 (2007) 614-616
12. Collinge J., Whitfield J., McKintosh E., Beck J., Mead S., Thomas D.J., and Alpers M.P. Kuru in the 21st century - an acquired human prion disease with very long incubation periods. Lancet 367 (2006) 2068-2074
13. Richt J.A., et al. Identification and characterization of two bovine spongiform encephalopathy cases diagnosed in the United States. J. Vet. Diagn. Invest. 19 (2007) 142-154
14. Casalone C., Zanusso G., Acutis P., Ferrari S., Capucci L., Tagliavini F., Monaco S., and Caramelli M. Identification of a second bovine amyloidotic spongiform encephalopathy: molecular similarities with sporadic Creutzfeldt-Jakob disease. Proc. Natl. Acad. Sci. USA 101 (2004) 3065-3070
15. Glatzel M., Rogivue C., Ghani A., Streffer J.R., Amsler L., and Aguzzi A. Incidence of Creutzfeldt-Jakob disease in Switzerland. Lancet 360 (2002) 139-1341
16. Sigurdson C.J. A prion disease of cervids: chronic wasting disease. Vet. Res. 39 (2008) 41
17. Aguzzi A., and Heikenwalder M. Prions, cytokines, and chemokines: a meeting in lymphoid organs. Immunity 22 (2005) 145-154
18. Wadsworth J.D.F., Joiner S., Hill A.F., Campbell T.A., Desbruslais M., Luthert P.J., and Collinge J. Tissue distribution of protease resistant prion protein in variant CJD using a highly sensitive immuno-blotting assay. Lancet 358 (2001) 171-180
19. Glatzel M., Abela E., Maissen M., and Aguzzi A. Extraneural pathologic prion protein in sporadic Creutzfeldt-Jakob disease. New Engl. J. Med. 349 (2003) 1812-1820
20. Peden A.H., Ritchie D.L., Head M.W., and Ironside J.W. Detection and localization of PrPSc in the skeletal muscle of patients with variant, iatrogenic, and sporadic forms of Creutzfeldt-Jakob disease. Am. J. Pathol. 168 (2006) 927-935
21. Tabaton M., Monaco S., Cordone M.P., Colucci M., Giaccone G., Tagliavini F., and Zanusso G. Prion deposition in olfactory biopsy of sporadic Creutzfeldt-Jakob disease. Ann. Neurol. 55 (2004) 294-296
22. Mathiason C.K., et al. Infectious prions in the saliva and blood of deer with chronic wasting disease. Science 314 (2006) 133-136
23. Angers R.C., Browning S.R., Seward T.S., Sigurdson C.J., Miller M.W., Hoover E.A., and Telling G.C. Prions in skeletal muscles of deer with chronic wasting disease. Science 311 (2006) 1117
24. Kovacs G.G., et al. Creutzfeldt-Jakob disease and inclusion body myositis: Alig. Ann. Neurol. 55 (2004) 121-125
25. Lacroux C., et al. Prions in milk from ewes incubating natural scrapie. PLoS Pathog. 4 (2008) e1000238
26. Ligios C., et al. PrPSc in mammary glands of sheep affected by scrapie and mastitis. Nat. Med. 11 (2005) 1137-1138
27. Heikenwalder M., et al. Chronic lymphocytic inflammation specifies the organ tropism of prions. Science 307 (2005) 1107-1110
28. Hamir A.N., Kunkle R.A., Miller J.M., and Hall S.M. Abnormal prion protein in ectopic lymphoid tissue in a kidney of an asymptomatic white-tailed deer experimentally inoculated with the agent of chronic wasting disease. Vet. Pathol. 43 (2006) 367-369
29. Seeger H., et al. Coincident scrapie infection and nephritis lead to urinary prion excretion. Science 310 (2005) 324-326
30. Sigurdson C.J., et al. Bacterial colitis increases susceptibility to oral prion disease. J. Infect. Dis. 199 (2009) 243-252
31. Aguzzi A., and Heikenwalder M. Pathogenesis of prion diseases: current status and future outlook. Nat. Rev. Microbiol. 4 (2006) 765-775
32. Kariv-Inbal Z., Ben-Hur T., Grigoriadis N.C., Engelstein R., and Gabizon R. Urine from scrapie-infected hamsters comprises low levels of prion infectivity. Neurodegener. Dis. 3 (2006) 123-128
33. Meyer-Luehmann M., et al. Exogenous induction of cerebral beta-amyloidogenesis is governed by agent and host. Science 313 (2006) 1781-1784
34. Aguzzi A., and Haass C. Games played by rogue proteins in prion disorders and Alzheimer's disease. Science 302 (2003) 814-818
35. Riek R. Cell biology: infectious Alzheimer's disease?. Nature 444 (2006) 429-431
36. Prusiner S.B. Novel proteinaceous infectious particles cause scrapie. Science 216 (1982) 136-144
37. Stahl N., Baldwin M.A., Teplow D.B., Hood L., Gibson B.W., Burlingame A.L., and Prusiner S.B. Structural studies of the scrapie prion protein using mass spectrometry and amino acid sequencing. Biochemistry 32 (1993) 1991-2002
38. Riek R., Hornemann S., Wider G., Billeter M., Glockshuber R., and Wüthrich K. NMR structure of the mouse prion protein domain PrP(121-231). Nature 382 (1996) 180-182
39. Pan K.M., et al. Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. Proc. Natl. Acad. Sci. USA 90 (1993) 10962-10966
40. Safar J., Roller P.P., Gajdusek D.C., and Gibbs Jr. C.J. Conformational transitions, dissociation, and unfolding of scrapie amyloid (prion) protein. J. Biol. Chem. 268 (1993) 20276-20284
41. Collinge J., and Clarke A.R. A general model of prion strains and their pathogenicity. Science 318 (2007) 930-936
42. Aguzzi A., Heikenwalder M., and Polymenidou M. Insights into prion strains and neurotoxicity. Nat. Rev. Mol. Cell Biol. 8 (2007) 552-561
43. Bartz J.C., Dejoia C., Tucker T., Kincaid A.E., and Bessen R.A. Extraneural prion neuroinvasion without lymphoreticular system infection. J. Virol. 79 (2005) 11858-11863
44. Aguzzi A. Understanding the diversity of prions. Nat. Cell Biol. 6 (2004) 290-292
45. Prusiner S.B., Cochran S.P., Groth D.F., Downey D.E., Bowman K.A., and Martinez H.M. Measurement of the scrapie agent using an incubation time interval assay. Ann. Neurol. 11 (1982) 353-358
46. Klohn P.C., Stoltze L., Flechsig E., Enari M., and Weissmann C. A quantitative, highly sensitive cell-based infectivity assay for mouse scrapie prions. Proc. Natl. Acad. Sci. USA 100 (2003) 11666-11671
47. McKinley M.P., Bolton D.C., and Prusiner S.B. A protease-resistant protein is a structural component of the scrapie prion. Cell 35 (1983) 57-62
48. Schulz-Schaeffer W.J., Fatzer R., Vandevelde M., and Kretzschmar H.A. Detection of PrP(Sc) in subclinical BSE with the paraffin-embedded tissue (PET) blot. Arch. Virol. Suppl. 16 (2000) 173-180
49. Taraboulos A., Jendroska K., Serban D., Yang S.L., DeArmond S.J., and Prusiner S.B. Regional mapping of prion proteins in brain. Proc. Natl. Acad. Sci. USA 89 (1992) 7620-7624
50. Saborio G.P., Permanne B., and Soto C. Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature 411 (2001) 810-813
51. Castilla J., Saa P., and Soto C. Detection of prions in blood. Nat. Med. 11 (2005) 982-985
52. Deleault N.R., Harris B.T., Rees J.R., and Supattapone S. Formation of native prions from minimal components in vitro. Proc. Natl. Acad. Sci. USA 104 (2007) 9741-9746
53. Sc molecules with different conformations. Nat. Med. 4 (1998) 1157-1165
54. Büeler H.R., et al. Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature 356 (1992) 577-582
55. Mallucci G., Dickinson A., Linehan J., Klohn P.C., Brandner S., and Collinge J. Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis. Science 302 (2003) 871-874
56. Linden R., Martins V.R., Prado M.A., Cammarota M., Izquierdo I., and Brentani R.R. Physiology of the prion protein. Physiol. Rev. 88 (2008) 673-728
57. Brandner S., Raeber A., Sailer A., Blattler T., Fischer M., Weissmann C., and Aguzzi A. Normal host prion protein (PrPC) is required for scrapie spread within the central nervous system. Proc. Natl. Acad. Sci. USA 93 (1996) 13148-13151
58. Chesebro B., et al. Anchorless prion protein results in infectious amyloid disease without clinical scrapie. Science 308 (2005) 1435-1439
59. Aguzzi A. Cell biology. Prion toxicity: all sail and no anchor. Science 308 (2005) 1420-1421
60. Lauren J., Gimbel D.A., Nygaard H.B., Gilbert J.W., and Strittmatter S.M. Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers. Nature 457 (2009) 1128-1132
61. Cisse M., and Mucke L. Alzheimer's disease: a prion protein connection. Nature 457 (2009) 1090-1091
62. Cashman N.R., Loertscher R., Nalbantoglu J., Shaw I., Kascsak R.J., Bolton D.C., and Bendheim P.E. Cellular isoform of the scrapie agent protein participates in lymphocyte activation. Cell 61 (1990) 185-192
63. Ballerini C., et al. Functional implication of cellular prion protein in antigen-driven interactions between T cells and dendritic cells. J. Immunol. 176 (2006) 7254-7262
64. Jouvin-Marche E., et al. Overexpression of cellular prion protein induces an antioxidant environment altering T cell development in the thymus. J. Immunol. 176 (2006) 3490-3497
65. Zabel M., Greenwood C., Thackray A.M., Pulford B., Rens W., and Bujdoso R. Perturbation of T-cell development by insertional mutation of a PrP transgene. Immunology 127 (2009) 226-236
66. de Almeida C.J., Chiarini L.B., da Silva J.P., PM E.S., Martins M.A., and Linden R. The cellular prion protein modulates phagocytosis and inflammatory response. J. Leukoc. Biol. 77 (2009) 238-246
67. Watarai M., Kim S., Erdenebaatar J., Makino S., Horiuchi M., Shirahata T., Sakaguchi S., and Katamine S. Cellular prion protein promotes Brucella infection into macrophages. J. Exp. Med. 198 (2003) 5-17
68. Aguzzi A., and Hardt W.D. Dangerous liaisons between a microbe and the prion protein. J. Exp. Med. 198 (2003) 1-4
69. Fontes P., Alvarez-Martinez M.T., Gross A., Carnaud C., Kohler S., and Liautard J.P. Absence of evidence for the participation of the macrophage cellular prion protein in infection with Brucella suis. Infect. Immun. 73 (2005) 6229-6236
70. Zhang C.C., Steele A.D., Lindquist S., and Lodish H.F. Prion protein is expressed on long-term repopulating hematopoietic stem cells and is important for their self-renewal. Proc. Natl. Acad. Sci. USA 103 (2006) 2184-2189
71. Steele A.D., Lindquist S., and Aguzzi A. The prion protein knockout mouse: a phenotype under challenge. Prion 1 (2007) 83-93
72. McGovern G., Brown K.L., Bruce M.E., and Jeffrey M. Murine scrapie infection causes an abnormal germinal centre reaction in the spleen. J. Comp. Pathol. 130 (2004) 181-194
73. Clarke M.C., and Haig D.A. Multiplication of scrapie agent in mouse spleen. Res. Vet. Sci. 12 (1971) 195-197
74. Kimberlin R.H., and Walker C.A. The role of the spleen in the neuroinvasion of scrapie in mice. Virus Res. 12 (1989) 201-211
75. Kimberlin R.H., and Walker C.A. Pathogenesis of scrapie (strain 263K) in hamsters infected intracerebrally, intraperitoneally or intraocularly. J. Gen. Virol. 67 (1986) 255-263
76. Mohri S., Handa S., and Tateishi J. Lack of effect of thymus and spleen on the incubation period of Creutzfeldt-Jakob disease in mice. J. Gen. Virol. 68 (1987) 1187-1189
77. Manuelidis E.E., Gorgacz E.J., and Manuelidis L. Transmission of Creutzfeldt-Jakob disease with scrapie-like syndromes to mice. Nature 271 (1978) 778-779
78. Lavelle G.C., Sturman L., and Hadlow W.J. Isolation from mouse spleen of cell populations with high specific infectivity for scrapie virus. Infect. Immun. 5 (1972) 319-323
79. Clarke M.C., and Kimberlin R.H. Pathogenesis of mouse scrapie: distribution of agent in the pulp and stroma of infected spleens. Vet. Microbiol. 9 (1984) 215-225
80. Fraser H., and Farquhar C.F. Ionising radiation has no influence on scrapie incubation period in mice. Vet. Microbiol. 13 (1987) 211-223
81. Kaeser P.S., Klein M.A., Schwarz P., and Aguzzi A. Efficient lymphoreticular prion propagation requires PrP(c) in stromal and hematopoietic cells. J. Virol. 75 (2001) 7097-7106
82. Blättler T., Brandner S., Raeber A.J., Klein M.A., Voigtländer T., Weissmann C., and Aguzzi A. PrP-expressing tissue required for transfer of scrapie infectivity from spleen to brain. Nature 389 (1997) 69-73
83. Priller J., Prinz M., Heikenwalder M., Zeller N., Schwarz P., and Aguzzi A. Early and rapid engraftment of bone marrow-derived microglia in scrapie. J. Neuorsci. 26 (2006) 11753-11762
84. Klein M.A., et al. A crucial role for B cells in neuroinvasive scrapie. Nature 390 (1997) 687-690
85. Klein M.A., Frigg R., Raeber A.J., Flechsig E., Hegyi I., Zinkernagel R.M., Weissmann C., and Aguzzi A. PrP expression in B lymphocytes is not required for prion neuroinvasion. Nat. Med. 4 (1998) 1429-1433
86. Montrasio F., et al. B lymphocyte-restricted expression of prion protein does not enable prion replication in prion protein knockout mice. Proc. Natl. Acad. Sci. USA 98 (2001) 4034-4037
87. Kitamoto T., Muramoto T., Mohri S., Doh ura K., and Tateishi J. Abnormal isoform of prion protein accumulates in follicular dendritic cells in mice with Creutzfeldt-Jakob disease. J. Virol. 65 (1991) 6292-6295
88. Browning J.L. Inhibition of the lymphotoxin pathway as a therapy for autoimmune disease. Immunol. Rev. 223 (2008) 202-220
89. Montrasio F., Frigg R., Glatzel M., Klein M.A., Mackay F., Aguzzi A., and Weissmann C. Impaired prion replication in spleens of mice lacking functional follicular dendritic cells. Science 288 (2000) 1257-1259
90. Kranich J., et al. Follicular dendritic cells control engulfment of apoptotic bodies by secreting Mfge8. J. Exp. Med. 205 (2008) 1293-1302
91. Klein M.A., et al. Complement facilitates early prion pathogenesis. Nat. Med. 7 (2001) 488-492
92. Mabbott N.A., Bruce M.E., Botto M., Walport M.J., and Pepys M.B. Temporary depletion of complement component C3 or genetic deficiency of C1q significantly delays onset of scrapie. Nat. Med. 7 (2001) 485-487
93. Zabel M.D., et al. Stromal complement receptor CD21/35 facilitates lymphoid prion colonization and pathogenesis. J. Immunol. 179 (2007) 6144-6152
94. Felten S.Y., Felten D.L., Bellinger D.L., Carlson S.L., Ackerman K.D., Madden K.S., Olschowka J.A., and Livnat S. Noradrenergic sympathetic innervation of lymphoid organs. Prog Allergy 43 (1988) 14-36
95. Cole S., and Kimberlin R.H. Pathogenesis of mouse scrapie: dynamics of vacuolation in brain and spinal cord after intraperitoneal infection. Neuropathol. Appl. Neurobiol. 11 (1985) 213-227
96. McBride P.A., and Beekes M. Pathological PrP is abundant in sympathetic and sensory ganglia of hamsters fed with scrapie. Neurosci. Lett. 265 (1999) 135-138
97. Haik S., Faucheux B.A., Sazdovitch V., Privat N., Kemeny J.L., Perret-Liaudet A., and Hauw J.J. The sympathetic nervous system is involved in variant Creutzfeldt-Jakob disease. Nat Med 9 (2003) 1121-1122
98. Glatzel M., Heppner F.L., Albers K.M., and Aguzzi A. Sympathetic innervation of lymphoreticular organs is rate limiting for prion neuroinvasion. Neuron 31 (2001) 25-34
99. Glatzel M., and Aguzzi A. PrP(C) expression in the peripheral nervous system is a determinant of prion neuroinvasion. J. Gen. Virol. 81 (2000) 2813-2821
100. Heinen E., Bosseloir A., and Bouzahzah F. Follicular dendritic cells: origin and function. Curr. Top. Microbiol. Immunol. 201 (1995) 15-47
101. Prinz M., et al. Positioning of follicular dendritic cells within the spleen controls prion neuroinvasion. Nature 425 (2003) 957-962
102. Forster R., Mattis A.E., Kremmer E., Wolf E., Brem G., and Lipp M. A putative chemokine receptor, BLR1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen. Cell 87 (1996) 1037-1047
103. Beekes M., and McBride P.A. Early accumulation of pathological PrP in the enteric nervous system and gut-associated lymphoid tissue of hamsters orally infected with scrapie. Neurosci. Lett. 278 (2000) 181-184
104. Mabbott N.A., Young J., McConnell I., and Bruce M.E. Follicular dendritic cell dedifferentiation by treatment with an inhibitor of the lymphotoxin pathway dramatically reduces scrapie susceptibility. J. Virol. 77 (2003) 6845-6854
105. Heikenwalder M., et al. Germinal center B cells are dispensable in prion transport and neuroinvasion. J. Neuroimmunol. 192 (2007) 113-123
106. Aucouturier P., Geissmann F., Damotte D., Saborio G.P., Meeker H.C., Kascsak R., Carp R.I., and Wisniewski T. Infected splenic dendritic cells are sufficient for prion transmission to the CNS in mouse scrapie. J. Clin. Invest. 108 (2001) 703-708
107. Raymond C.R., and Mabbott N.A. Assessing the involvement of migratory dendritic cells in the transfer of the scrapie agent from the immune to peripheral nervous systems. J. Neuroimmunol. 187 (2007) 114-125
108. Brown K.L., Stewart K., Ritchie D.L., Mabbott N.A., Williams A., Fraser H., Morrison W.I., and Bruce M.E. Scrapie replication in lymphoid tissues depends on prion protein-expressing follicular dendritic cells. Nat. Med. 5 (1999) 1308-1312
109. Prinz M., Montrasio F., Klein M.A., Schwarz P., Priller J., Odermatt B., Pfeffer K., and Aguzzi A. Lymph nodal prion replication and neuroinvasion in mice devoid of follicular dendritic cells. Proc. Natl. Acad. Sci. USA 99 (2002) 919-924
110. Mabbott N.A., McGovern G., Jeffrey M., and Bruce M.E. Temporary blockade of the tumor necrosis factor receptor signaling pathway impedes the spread of scrapie to the brain. J. Virol. 76 (2002) 5131-5139
111. Hamir A.N., Kunkle R.A., Richt J.A., Miller J.M., Cutlip R.C., and Jenny A.L. Experimental transmission of sheep scrapie by intracerebral and oral routes to genetically susceptible Suffolk sheep in the United States. J. Vet. Diagn. Invest. 17 (2005) 3-9
112. Mackay F., and Browning J.L. Turning off follicular dendritic cells. Nature 395 (1998) 26-27
113. Dlakic W.M., Grigg E., and Bessen R.A. Prion infection of muscle cells in vitro. J. Virol. 81 (2007) 4615-4624
114. Oldstone M.B., et al. Lymphotoxin-alpha- and lymphotoxin-beta-deficient mice differ in susceptibility to scrapie: evidence against dendritic cell involvement in neuroinvasion. J. Virol. 76 (2002) 4357-4363
115. Vorberg I., Buschmann A., Harmeyer S., Saalm ller A., Pfaff E., and Groschup M.H. A novel epitope for the specific detection of exogenous prion proteins in transgenic mice and transfected murine cell lines. Virology 255 (1999) 26-31
116. Mahal S.P., Baker C.A., Demczyk C.A., Smith E.W., Julius C., and Weissmann C. Prion strain discrimination in cell culture: the cell panel assay. Proc. Natl. Acad. Sci. USA 104 (2007) 20908-20913
117. Heikenwalder M., et al. Lymphotoxin-dependent prion replication in inflammatory stromal cells of granulomas. Immunity 29 (2008) 998-1008
118. Thomzig A., Schulz-Schaeffer W., Wrede A., Wemheuer W., Brenig B., Kratzel C., Lemmer K., and Beekes M. Accumulation of pathological prion protein PrPSc in the skin of animals with experimental and natural scrapie. PLoS Pathog. 3 (2007) e66
119. Aguzzi A., and Sigurdson C.J. Antiprion immunotherapy: to suppress or to stimulate?. Nat. Rev. Immunol. 4 (2004) 725-736
120. Sethi S., Lipford G., Wagner H., and Kretzschmar H. Postexposure prophylaxis against prion disease with a stimulator of innate immunity. Lancet 360 (2002) 229-230
121. Prinz M., Heikenwalder M., Schwarz P., Takeda K., Akira S., and Aguzzi A. Prion pathogenesis in the absence of Toll-like receptor signalling. EMBO Rep. 4 (2003) 195-199
122. Heikenwalder M., Polymenidou M., Junt T., Sigurdson C., Wagner H., Akira S., Zinkernagel R., and Aguzzi A. Lymphoid follicle destruction and immunosuppression after repeated CpG oligodeoxynucleotide administration. Nat. Med. 10 (2004) 187-192
123. Gabizon R., McKinley M.P., Groth D., and Prusiner S.B. Immunoaffinity purification and neutralization of scrapie prion infectivity. Proc. Natl. Acad. Sci. USA 85 (1988) 6617-6621
124. Horiuchi M., and Caughey B. Specific binding of normal prion protein to the scrapie form via a localized domain initiates its conversion to the protease-resistant state. EMBO J. 18 (1999) 3193-3203
125. Enari M., Flechsig E., and Weissmann C. Scrapie prion protein accumulation by scrapie-infected neuroblastoma cells abrogated by exposure to a prion protein antibody. Proc. Natl. Acad. Sci. USA 98 (2001) 9295-9299
126. Peretz D., et al. Antibodies inhibit prion propagation and clear cell cultures of prion infectivity. Nature 412 (2001) 739-743
127. Heppner F.L., et al. Prevention of scrapie pathogenesis by transgenic expression of anti-prion protein antibodies. Science 294 (2001) 178-182
128. Sigurdsson E.M., et al. Immunization delays the onset of prion disease in mice. Am. J. Pathol. 161 (2002) 13-17
129. Polymenidou M., et al. Humoral immune response to native eukaryotic prion protein correlates with anti-prion protection. Proc. Natl. Acad. Sci. USA 101 (2004) 14670-14676
130. Goni F., et al. High titers of mucosal and systemic anti-PrP antibodies abrogate oral prion infection in mucosal-vaccinated mice. Neuroscience 153 (2008) 679-686
131. White A.R., et al. Monoclonal antibodies inhibit prion replication and delay the development of prion disease. Nature 422 (2003) 80-83
132. Solforosi L., et al. Cross-linking cellular prion protein triggers neuronal apoptosis in vivo. Science 303 (2004) 1514-1516
133. Markovits P., Dautheville C., Dormont D., Dianoux L., and Latarjet R. In vitro propagation of the scrapie agent. I. Transformation of mouse glia and neuroblastoma cells after infection with the mouse-adapted scrapie strain c-506. Acta Neuropathol. Berl. 60 (1983) 75-80
134. Race R.E., Fadness L.H., and Chesebro B. Characterization of scrapie infection in mouse neuroblastoma cells. J. Gen. Virol. 68 (1987) 1391-1399
135. Nishida N., et al. Successful transmission of three mouse-adapted scrapie strains to murine neuroblastoma cell lines overexpressing wild-type mouse prion protein. J. Virol. 74 (2000) 320-325
136. Ladogana A., Liu Q., Xi Y.G., and Pocchiari M. Proteinase-resistant protein in human neuroblastoma cells infected with brain material from Creutzfeldt-Jakob patient. Lancet 345 (1995) 594-595
137. Rubenstein R., Carp R.I., and Callahan S.M. In vitro replication of scrapie agent in a neuronal model: infection of PC12 cells. J. Gen. Virol. 65 (1984) 2191-2198
138. Schätzl H.M., Laszlo L., Holtzman D.M., Tatzelt J., DeArmond S.J., Weiner R.I., Mobley W.C., and Prusiner S.B. A hypothalamic neuronal cell line persistently infected with scrapie prions exhibits apoptosis. J. Virol. 71 (1997) 8821-8831
139. Baron G.S., Magalhaes A.C., Prado M.A., and Caughey B. Mouse-adapted scrapie infection of SN56 cells: greater efficiency with microsome-associated versus purified PrP-res. J. Virol. 80 (2006) 2106-2117
140. Maas E., Geissen M., Groschup M.H., Rost R., Onodera T., Schätzl H., and Vorberg I.M. Scrapie infection of prion protein-deficient cell line upon ectopic expression of mutant prion proteins. J.Biol. Chem. 282 (2007) 18702-18710
141. Cronier S., Laude H., and Peyrin J.M. Prions can infect primary cultured neurons and astrocytes and promote neuronal cell death. Proc. Natl. Acad. Sci. USA. 101 (2004) 12271-12276
142. Milhavet O C.D., Chevallier N., McKay R.D., and McKayLehmann S. Neural stem cell model for prion propagation. Stem Cells 24 (2006) 2284-2291
143. Clarke M.C., and Haig D.A. Evidence for the multiplication of scrapie agent in cell culture. Nature 225 (1970) 100-101
144. Birkett C.R., Hennion R.M., Bembridge D.A., Clarke M.C., Chree A., Bruce M.E., and Bostock C.J. Scrapie strains maintain biological phenotypes on propagation in a cell line in culture. EMBO J. 20 (2001) 3351-3358
145. Clarke M.C., and Millson G.C. Infection of a cell line of mouse L fibroblasts with scrapie agent. Nature 261 (1976) 144-145
146. Cherednichenko Yu N., Mikhailova G.R., Rajcani J., and Zhdanov V.M. In vitro studies with the scrapie agent. Acta Virol. 29 (1985) 285-293
147. Vorberg I., Raines A., Story B., and Priola S.A. Susceptibility of common fibroblast cell lines to transmissible spongiform encephalopathy agents. J. Infect. Dis. 189 (2004) 431-439
148. Elleman C.J. Attempts to establish the scrapie agent in cell lines. Vet. Res. Commun. 8 (1984) 309-316
149. Roikhel V.M., Fokina G.I., Lisak V.M., Kondakova L.I., Korolev M.B., and Pogodina V.V. Persistence of the scrapie agent in glial cells from rat Gasserian ganglion. Acta Virol. 31 (1987) 36-42
150. Taraboulos A., Serban D., and Prusiner S.B. Scrapie prion proteins accumulate in the cytoplasm of persistently infected cultured cells. J. Cell Biol. 110 (1990) 2117-2132
151. Iwamaru T.T., Ogihara K., Hoshino M., Takata M., Imamura M., Tagawa Y., Hayashi-Kato H., Ushiki-Kaku Y., Shimizu Y., Okada H., Shinagawa M., Kitani H., and Yokoyama T. Microglial cell line established from prion protein-overexpressing mice is susceptible to various murine prion strains. J. Virol. 81 (2007) 1524-1527
152. Follet J., et al. PrP expression and replication by Schwann cells: implications in prion spreading. J. Virol. 76 (2002) 2434-2439
153. Archer F., et al. Cultured peripheral neuroglial cells are highly permissive to sheep prion infection. J. Virol. 78 (2004) 482-4890
154. Raymond G.J., et al. Inhibition of protease-resistant prion protein formation in a transformed deer cell line infected with chronic wasting disease. J. Virol. 80 (2006) 596-604
155. Vilette D., Andreoletti O., Archer F., Madelaine M.F., Vilotte J.L., Lehmann S., and Laude H. Ex vivo propagation of infectious sheep scrapie agent in heterologous epithelial cells expressing ovine prion protein. Proc. Natl. Acad. Sci. USA 98 (2001) 4055-4059
156. Courageot M.P., et al. A cell line infectible by prion strains from different species. J. Gen. Virol. 89 (2008) 341-347
157. Vella L.J., Sharples R.A., Lawson V.A., Masters C.L., Cappai R., and Hill A.F. Packaging of prions into exosomes is associated with a novel pathway of PrP processing. J. Pathol. 211 (2007) 582-590